Cell Line Development Market Will Reach $6.24 Billion By 2022: Grand View Research, Inc.
Global cell line development market size is expected to
reach USD 6.24 billion by 2022, according to a new report by Grand View
Research, Inc. The Increasing demand for monoclonal antibodies and patent
expiration of blockbuster biologics are expected to drive the cell line
development industry over the forecast period.
Increasing
prevalence of autoimmune diseases and cancer are likely to increase the demand
for accurate and cost effective treatment options which is expected to render a
positive impact on market growth. In addition, improving healthcare
infrastructure, economic development and favorable government initiatives
promoting the growth of the biotechnology industry are factors contributing
towards the growth of the cell line development market.
Ongoing
R&D for stable & authentic cell lines and the introduction of
technologically advanced processes such as single use bioreactor and micro
bioreactor for large scale bioproduction are further expected to provide this
market with lucrative future growth opportunities.
U.S. cell
line development market, by type, 2012 - 2022 (USD Million)
Browse full
research report on Cell Line Development Market:
Further
key findings from the report suggest:
- Reagent
and media was the largest product market in 2014, owing to increasing
number of cell culture procedures. Reagent and media are necessary
components involved in cell line development procedures & cell culture
and are cost intensive in nature. The market for reagent and media was
valued at over 1.0 billion in 2014.
- Mammalian
cell lines were widely used as a source for cell line development in 2014,
owing to associated advantages such as accurate complex protein expression
nature, critical for the production of monoclonal antibodies, vaccines,
and biologics.
- Cell
line development finds the largest application in the bioproduction of
biologics, vaccines, Mabs, therapeutic proteins and biosimilars. Rising
demand for monoclonal antibodies and vaccines are expected to boost the
growth of this segment over the forecast period. The market for cell line
development based bioproduction is also expected to witness lucrative
growth of over 12.5% during the forecast period.
- North
America was the largest market in 2014, with revenue estimated at over 800
million. The region’s market dominance is attributed to factors such as
the growing adoption rates of cell culture techniques, presence of well
developed healthcare infrastructure, supportive government initiatives and
high healthcare expenditure levels.
- Asia
Pacific cell line development market is anticipated to register rapid
growth over the forecast period owing to factors such as the presence of
high unmet needs, rising number of CROs (Contract Research Organization)
providing pertinent services, growing R&D investments aimed at the
development of stable cell lines and increasing biologics production.
- Key
players in this market include European Collection of cell Cultures
(ECACC), Lonza Group AG, GE Healthcare, Thermo Fisher Scientific Inc.,
Sartorious AG, Selexis SA, Wuxi AppTec Inc., Sigma-Aldrich Corporation,
American Type Culture Collection (ATCC) and Corning Inc.
Browse more
reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/clinical-diagnostics
For the purpose of this study, Grand View Research has segmented the
global cell line development market on the basis of product, source, type of
cell line, application and region:
Global Cell
Line Development Product Outlook (Revenue, USD Million, 2012 - 2022)
- Reagents
and media
- Equipment
Accessories and consumables
- Incubators
- Centrifuges
- Bioreactors
- Storage
equipment
- Microscopes
Global Cell
Line Development Source Outlook (Revenue, USD Million, 2012 - 2022)
- Mammalian
- Non
mammalian
- Insects
- Amphibians
Global Cell
Line Development Type Of Cell Line Outlook (Revenue, USD Million, 2012 - 2022)
- Recombinant
cell lines
- Hybridomas
- Continuous
cell line
- Primary
cell lines
Global Cell
Line Development Application Outlook (Revenue, USD Million, 2012 - 2022)
- Bioproduction
- Drug
discovery
- Toxicity
testing
- Tissue
engineering
- Research
Cell Line
Development Regional Outlook (Revenue, USD Billion, 2014 - 2022)
- North
America
- U.S.
- Canada
- Europe
- Germany
- UK
- Asia
Pacific
- China
- Japan
- India
- Latin
America
- Mexico
- Brazil
- MEA
- South Africa
Access
Press Release By Grand View Research: http://www.grandviewresearch.com/press-release/global-cell-line-development-market
About Grand
View Research:
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research
reports, and consulting services. To help clients make informed business
decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
Comments
Post a Comment